Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
The Analyst Verdict: Amphastar Pharma In The Eyes Of 4 Experts - Amphastar Pharma (NASDAQ:AMPH)
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Amphastar Pharma (NASDAQ:) in the last three months. The table below summarizes their recent ratings, showcasing the evolving sentiments within…
OptimizerRx outlines $118M-$124M 2026 revenue target amid early contract visibility and digital pharma momentum (NASDAQ:OPRX)
Earnings Call Insights: OptimizeRx Corporation (OPRX) Q3 2025 CEO Stephen Silvestro reported a strong third quarter with revenues increasing 22% year-over-year to $26.1 million and adjusted EBITDA of $5.1 million, noting 'results ahead of both…
Urogen Pharma (NASDAQ:URGN) Announces Earnings Results
Urogen Pharma (NASDAQ:URGN - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.69) earnings per share for the quarter, topping analysts' consensus estimates of ($0.72) by $0.03, Zacks reports. The firm…
Torrent Pharma report 30.5% rise in net profit for Q2 FY26
Torrent Pharmaceuticals Ltd, the flagship company of Torrent Group reported a 30.5 per cent year-on-year rise in net profit that stood at ₹591 crore for the second quarter of the financial year 2025-26. During the quarter, the revenues of…
FY2025 EPS Estimate for Nuvectis Pharma Decreased by Analyst
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) - Analysts at HC Wainwright dropped their FY2025 earnings per share estimates for Nuvectis Pharma in a research note issued to investors on Tuesday, November 4th. HC Wainwright analyst J. Pantginis…
Royalty Pharma (NASDAQ:RPRX) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS
Royalty Pharma (NASDAQ:RPRX - Get Free Report) posted its quarterly earnings data on Wednesday. The biopharmaceutical company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.11 by $0.06, Zacks reports. Royalty Pharma had a…
Innate Pharma (IPHA) Projected to Post Quarterly Earnings on Thursday
Innate Pharma (NASDAQ:IPHA - Get Free Report) is expected to announce its results before the market opens on Thursday, November 13th. Analysts expect the company to announce earnings of ($0.3285) per share and revenue of $1.96 million for the…
FY2025 EPS Forecast for Nuvectis Pharma Lowered by Analyst
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) - Investment analysts at Roth Capital lowered their FY2025 earnings estimates for Nuvectis Pharma in a research note issued on Tuesday, November 4th. Roth Capital analyst J. Aschoff now anticipates…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading Down 13.7% - Here's What Happened
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) shares traded down 13.7% on Thursday. The stock traded as low as $64.6450 and last traded at $64.6450. 368 shares were traded during mid-day trading, a decline of 53% from the average session…
Urogen Pharma (NASDAQ:URGN) Sets New 1-Year High After Strong Earnings
Shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) hit a new 52-week high during mid-day trading on Thursday following a stronger than expected earnings report. The stock traded as high as $23.00 and last traded at $22.1330, with a volume of…
Piper Sandler Initiates Coverage on Ascentage Pharma Group International (NASDAQ:AAPG)
Equities researchers at Piper Sandler initiated coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) in a research report issued on Wednesday, Marketbeat.com reports. The firm set an 'overweight' rating and a…
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) had its price objective raised by Royal Bank Of Canada from $39.00 to $44.00 in a report released on Thursday, Benzinga reports. The brokerage presently has an 'outperform' rating on the stock.
/dq/media/media_files/2025/11/07/c-balaji-2025-11-07-12-51-00.jpg)
The future isn't about isolated robots
C Balaji, PSG Head, TVS Electronics draws a rough, but realistic, picture of factories that embrace robots for new business models as well as faster (and smarter) assembly lines and packaging. It's an age of managed automation, performance-based…
CDSCO orders drugmakers to meet global standards by January after cough syrup deaths
India's drug regulator on Friday ordered state authorities to ensure all pharmaceutical factories comply with international manufacturing standards by January, rejecting industry pleas for more time after toxic cough syrup was linked to additional…
The Club's top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, Nov. 7 1. The stock market was trending toward a lower open this morning as the government shutdown and ongoing scrutiny of AI-related names continue to weigh on stocks. The S & P 500 and tech-heavy Nasdaq are both…
Receive a Daily briefing on Pharma Industry News
Get Started